• Explore /
  • Poster
  • / The therapeutic strategy for choosing lenvatinib in systemic therapy for unresectable hepatocellular carcinoma.

The therapeutic strategy for choosing lenvatinib in systemic therapy for unresectable hepatocellular carcinoma.

Abstract Poster

Authors

null

Kaoru Tsuchiya

Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

Kaoru Tsuchiya , Masayuki Kurosaki , Yutaka Yasui , Shun Kaneko , Sakura Kirino , Kento Inada , Yuki Tanaka , Shun Ishido , Koji Yamashita , Tsubasa Nobusawa , Yuka Hayakawa , Hiroaki Matsumoto , Tatsuya Kakegawa , Mayu Higuchi , Kenta Takaura , Shohei Tanaka , Chiaki Maeyashiki , Nobuharu Tamaki , Hiroyuki Nakanishi , Namiki Izumi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

DOI

10.1200/JCO.2022.40.4_suppl.447

Abstract #

447

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Hirokazu Takahashi

First Author: David Edward Kaplan

First Author: Arndt Vogel

First Author: Jamie Grossman